Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-08-15 Purchase | 2025-08-19 8:15 pm | Atara Biotherapeutics Inc. | ATRA | Panacea Innovation Ltd Huang James 10% Owner | 55,000 | $12.19 | $670,423 | 1,405,000 (Indirect) | View |
| 2025-07-17 Purchase | 2025-07-21 09:00 am | Atara Biotherapeutics Inc. | ATRA | Panacea Innovation Ltd Huang James 10% Owner | 19,335 | $9.6391 | $186,372 | 1,350,000 (Indirect) | View |
| 2022-09-06 Purchase | 2022-09-08 6:51 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 55,573 | $4.1326 | $229,662 | 371,708 (Indirect Direct) | View |
| 2022-08-31 Purchase | 2022-09-02 7:35 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 37,196 | $3.7379 | $139,036 | 316,135 (Indirect Direct) | View |
| 2022-08-24 Purchase | 2022-08-26 8:48 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 44,527 | $3.749 | $166,930 | 278,939 (Indirect Direct) | View |
| 2022-08-19 Purchase | 2022-08-23 8:19 pm | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 234,221 | $3.328 | $779,477 | 234,412 (Indirect Direct) | View |
| 2021-10-19 Purchase | 2021-10-19 4:56 pm | WINDTREE THERAPEUTICS INC | WINT | Huang James Director | 50,000 | $1.9027 | $95,135 | 2,628,134 (Indirect Direct) | View |
| 2021-09-01 Purchase | 2021-09-03 5:21 pm | ZIOPHARM ONCOLOGY INC | ZIOP | Huang James Director | 100,000 | $1.71 | $171,000 | 108,333 (Direct) | View |
| 2021-03-31 Purchase | 2021-04-02 5:13 pm | WINDTREE THERAPEUTICS INC | WINT | Huang James Director 10% Owner | 150,000 | $2.36 | $354,000 | 2,578,134 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-11-28 Tax Withholding | 2025-12-01 5:00 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Panacea Innovation Ltd Huang James 10% Owner | 1 | $14.03 | 1,712,899 (Indirect) | View |
| 2025-11-28 Exercise | 2025-12-01 5:00 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Panacea Innovation Ltd Huang James 10% Owner | 48,737 | $6.6099 | 1,712,899 (Indirect) | View |
| 2025-11-28 Exercise | 2025-12-01 5:00 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Panacea Innovation Ltd Huang James 10% Owner | 48,737 | $0.0001 | 1,712,899 (Indirect) | View |
Ownership | 2025-05-21 6:00 pm | N/A N/A | Atara Biotherapeutics Inc. | ATRA | Panacea Innovation Ltd Huang James 10% Owner | 0 | $0 | 1,638,565 (Indirect) | View |
| 2023-06-06 Option Award | 2023-06-08 5:22 pm | N/A 2033-06-05 | Alaunos Therapeutics Inc. | TCRT | Huang James Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-02-22 Exercise | 2023-02-23 4:30 pm | 2023-02-22 2023-02-22 | WINDTREE THERAPEUTICS INC | WINT | Huang James Director | 1,112,308 | $0 | 7,082,366 (Indirect) | View |
| 2023-02-22 Exercise | 2023-02-23 4:30 pm | N/A N/A | WINDTREE THERAPEUTICS INC | WINT | Huang James Director | 1,112,308 | $0.1411 | 7,082,366 (Indirect) | View |
| 2023-02-22 Option Award | 2023-02-23 4:30 pm | 2023-02-22 2023-02-22 | WINDTREE THERAPEUTICS INC | WINT | Huang James Director | 3,336,924 | $0 | 7,082,366 (Indirect) | View |
| 2022-06-22 Option Award | 2022-06-24 4:35 pm | N/A 2032-06-21 | Alaunos Therapeutics Inc. | TCRT | Huang James Director | 180,000 | $0 | 288,333 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 4:31 pm | N/A 2032-06-21 | Alaunos Therapeutics Inc. | TCRT | Huang James Director | 180,000 | $0 | 288,333 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 8:16 pm | 2023-06-07 2032-06-07 | WINDTREE THERAPEUTICS INC | WINT | Huang James Director | 12,500 | $0 | 2,640,634 (Direct) | View |
| 2022-05-25 Option Award | 2022-05-26 4:23 pm | N/A 2032-05-25 | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 397,419 | $0 | 397,419 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 8:03 pm | 2022-06-15 2031-06-15 | WINDTREE THERAPEUTICS INC | WINT | Huang James Director | 15,000 | $0 | 2,593,134 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-16 4:01 pm | N/A 2031-06-15 | CASI Pharmaceuticals Inc. | CASI | Huang James Director | 113,028 | $0 | 113,028 (Direct) | View |
Ownership | 2021-05-12 8:17 pm | N/A N/A | Orion Biotech Opportunities Corp. | ORIA | Huang James Chief Executive Officer | 0 | $0 | 5,630,000 (Indirect) | View |
| 2021-03-04 Option Award | 2021-05-06 7:22 pm | N/A 2031-03-03 | ZIOPHARM ONCOLOGY INC | ZIOP | Huang James Director | 70,833 | $0 | 70,833 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 9:13 pm | 2021-02-03 2031-02-03 | WINDTREE THERAPEUTICS INC | WINT | Huang James Director 10% Owner | 15,000 | $0 | 2,443,134 (Direct) | View |